IP Library Patent Application 12716828
Patent Application
App. No. 12/716,828

Remodeling of Tissues and Organs

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/716,828
Abstract

The invention provides methods of repairing damage to, or defects in, mammalian tissues or organs. In these methods, a particulate or non-particulate acellular matrix made from a tissue or organ other than the tissue or organ being repaired is placed in or on the organ or tissue that is being repaired.

Claims (33)

1 - 14 . (canceled)

15 . A method of treatment, comprising

(a) identifying a mammalian subject as having a recipient organ, or tissue, in need of repair or amelioration; and

(b) placing a composition comprising a particulate acellular matrix made from a donor collagen-based organ or tissue in or on the recipient organ or tissue;

wherein the recipient organ or tissue is selected from the group consisting of skin, bone, cartilage, meniscus, dermis, myocardium, stomach, small intestine, large intestine, diaphragm, tendon, ligament, neural tissue, striated muscle, smooth muscle, bladder, and gingiva, and

wherein the recipient organ or tissue is different from the donor collagen-based organ or tissue.

16 . The method of claim 15 , wherein the collagen-based organ or tissue is dermis.

17 . The method of claim 15 , wherein the collagen-based organ or tissue is selected from the group consisting of fascia, umbilical cord, placenta, cardiac valve, ligament, tendon, artery, vein, neural connective tissue, and ureter.

18 . The method of claim 15 , wherein the mammalian subject is a human.

19 . The method of claim 15 , wherein the composition further comprises viable cells histocompatible with the subject.

20 . The method of claim 15 , wherein the cells are from the mammalian subject.

21 . The method of claim 20 , wherein the cells are selected from the group consisting of epidermal cells, keratinocytes. endothelial cells fibroblasts, embryonic stem cells, adult or embryonic mesenchymal stem cells, umbilical stem cells, prochondroblasts, chondroblasts, chondrocytes, pro-osteoblasts, osteocytes, osteoclasts, monocytes, pro-cardiomyoblasts, pericytes, cardiomyoblasts, cardiomyocytes, gingival epithelial cells, and periodontal ligament stem cells.

22 . The method of claim 15 , further comprising administration to the subject of one or more agents selected from the group consisting of a cell growth factor, an angiogenic factor, a differentiation factor, a cytokine, a hormone, and a chemokine.

23 . The method of claim 22 , wherein the one or more agents are in the composition placed in the subject.

24 . The method of claim 22 , wherein the administration comprises injecting or infusing the one or more agents into the mammalian subject separately from the composition.

25 . The method of claim 22 , wherein the administration comprises administering to the subject one or more expression vectors containing one or more nucleic acid sequences encoding the one or more agents, wherein each of the one or more nucleic acid sequences is operably linked to a transcriptional or a translational regulatory element.

26 . The method of claim 25 , wherein the one or more expression vectors are in one or more cells that are administered to the subject.

27 . The method of claim 26 , wherein the one or more cells are in the composition.

28 . The method of claim 15 , wherein the composition further comprises demineralized bone powder.

29 . The method of claim 15 , wherein the gingiva is, or is proximal to, receding gingiva.

30 . The method of claim 15 , wherein the gingiva comprises a dental extraction socket.

31 . The method of claim 28 , wherein the recipient organ or tissue is bone.

32 . The method of claim 31 , wherein the composition is placed within a defect in the bone.

33 . The method of claim 32 , further comprising covering the defect with a sheet of acellular tissue matrix.

34 . A bone graft composition, comprising:

a particulate acellular tissue matrix; and

demineralized bone powder.

35 . The composition of claim 34 , wherein the composition further includes a liquid carrier.

36 . The composition of claim 35 , wherein the composition forms a putty or paste.

37 . The composition of claim 35 , further including cells selected from epidermal cells, keratinocytes. endothelial cells fibroblasts, embryonic stem cells, adult or embryonic mesenchymal stem cells, umbilical stem cells, prochondroblasts, chondroblasts, chondrocytes, pro-osteoblasts, osteocytes, osteoclasts, monocytes, pro-cardiomyoblasts, pericytes, cardiomyoblasts, cardiomyocytes, gingival epithelial cells, and periodontal ligament stem cells.

38 . The composition of claim 34 , wherein the particulate acellular tissue matrix is produced by freezing a tissue matrix and fracturing the tissue matrix.

39 . A tissue repair composition comprising: a plurality of demineralized bone fragments and a carrier, wherein the carrier comprises at least one homogenized connective tissue.

40 . The tissue repair composition of claim 38 , wherein the composition is a gel, a paste, or a putty.

Assignments (7)
RELEASE OF SECURITY INTEREST 040098/0268 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0554 →
RELEASE OF SECURITY INTEREST 040291/0237 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0702 →
RELEASE OF SECURITY INTEREST 037845/0497 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0603 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY INTEREST Recorded Feb 17, 2016
From: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 037845/0497 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2010
From: LIVESEY, STEPHEN A.; MCQUILLAN, DAVID J.; BENIKER, HERBERT DANIEL; BOERBOOM, LAWRENCE E.
To: LIFECELL CORPORATION
Reel/Frame 024675/0595 →